Syndax Pharmaceuticals Insider Sold Shares Worth $784,776, According to a Recent SEC Filing
Michael A Metzger, Director, Chief Executive Officer, on July 08, 2026, sold 32,375 shares in Syndax Pharmaceuticals (SNDX) for $784,776. Following the Form 4 filing with the SEC, Metzger has control over a total of 484,843 common shares of the company, with 484,843 shares held directly. SEC Filing
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.